Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 29× · first seen 08-sep-2026 · last seen 16-nov-2026

Metformin

Current understanding

Cheap, long-studied; TAME trial framing made it the poster child for aging-as-indication.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Functional contribution of TERT to mitigation of endometrial stromal cell senescence by metformin through modulation of the AKT/mTOR axis.
13-nov-2026 novelty 3 per-area 3 strengthens
pubmed trial early human-rct
Effects of henagliflozin proline tablets versus metformin extended-release tablets on body composition in geriatric patients with newly diagnosed type 2 diabetes mellitus (HABIT-GEMs): study protocol for a multicentre, randomised, open-label trial.
11-nov-2026 novelty 3 per-area 3 strengthens
pubmed observational
Is metformin use associated with cognitive, physical and cardiovascular outcomes in older adults with type 2 diabetes? A secondary analysis of the SCOPE multicentre prospective cohort study.
09-nov-2026 novelty 2 per-area 2 strengthens
pubmed trial late human-rct
Targeting Accelerated Aging in COPD: The AMICO (A Trial of Metformin In COpd) Trial Design.
04-nov-2026 novelty 4 per-area 4 strengthens
pubmed review
Glucose-Lowering Therapies in Type 2 Diabetes-Associated Sarcopenia: Mechanisms, Clinical Evidence and a Muscle-Centred Framework.
17-oct-2026 novelty 3 per-area 2 mentions
pubmed review
Is there a role for senotherapeutics in the treatment of giant cell arteritis?
07-oct-2026 novelty 2 per-area 2 mentions
rss news report
Direct Pharmacological Activation of AMPK Modestly Extends Life in Short-Lived Species
07-oct-2026 novelty 2 per-area 2 mentions
pubmed review
Caloric restriction mimetics rewire the AMPK-mTOR-ULK1 signaling nexus to restore autophagic proteostasis in the aging brain.
05-oct-2026 novelty 2 per-area 2 strengthens
press news report
Supplements for Longevity Are Everywhere, but Do They Actually Work? Experts Break Down the Science
02-oct-2026 novelty 2 per-area 1 mentions
pubmed observational human-observational
Metformin in Elderly Patients With Type 2 Diabetes and Muscle Strength, Muscle Mass, and Physical Function: Positive or Negative Correlation?
01-oct-2026 novelty 3 per-area 3 strengthens
pubmed review
Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review.
19-sep-2026 novelty 2 per-area 2 strengthens
clinicaltrials trial early
Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors
14-sep-2026 novelty 2 per-area 2 mentions
pubmed review mechanism-plausible
Mitochondrial homeostasis in musculoskeletal diseases: From pathogenic mechanisms to precision therapies.
11-sep-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Mitochondria-targeted esculetin mitigates age-associated cardiac remodeling through coordinated activation of AMPK-SIRT1 and inhibition of p38 MAPK signaling.
10-sep-2026 novelty 3 per-area 3 strengthens
pubmed review
A Mechanism-Based Framework for Anti-Aging Strategies: From Metabolic Regulation to Senotherapy and Stem Cell-Based Interventions.
01-sep-2026 novelty 2 per-area 2 mentions
clinicaltrials trial early
Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
19-aug-2026 novelty 2 per-area 1 mentions
pubmed other mechanism-plausible
A Systems Pharmacology Model of Aging Identifies Optimal Combination Therapies With Secondary Benefits on Weight Loss and Metabolic Health.
01-aug-2026 novelty 3 per-area 3 strengthens
pubmed review
Metformin: A Promising Candidate for Slowing the Progression of Cardiovascular Aging.
01-aug-2026 novelty 2 per-area 2 strengthens
pubmed review
Aging-related metabolic dysregulation in osteoporosis: mechanisms and therapeutic strategies.
27-jul-2026 novelty 2 per-area 1 mentions
pubmed preclinical
p38 MAPK and MDT-15 mediate SKN-1-dependent metformin-induced protection against mitis group streptococci in Caenorhabditis elegans.
27-jul-2026 novelty 2 per-area 2 strengthens
pubmed review
Senomorphic agents: Multi-target strategies to tame the senescence-associated secretory phenotype for healthy ageing.
24-jul-2026 novelty 2 per-area 2 strengthens
pubmed review
Rethinking frailty as a disorder of mitochondrial adaptability, from energetic congestion to systemic vulnerability.
19-jul-2026 novelty 3 per-area 2 mentions
pubmed review
Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways.
16-jul-2026 novelty 2 per-area 1 mentions
pubmed preclinical
TRF2 enriched cytoplasmic chromatin drives cGAS-STAT1-mediated inflammation in senescence.
14-jul-2026 novelty 3 per-area 2 strengthens
pubmed review
Aging-driven metabolic abnormalities remodel intercellular communication through the gut-liver-heart axis and may promote coronary artery disease: the key role of bile acid metabolism.
06-jul-2026 novelty 2 per-area 2 mentions
pubmed review
Effects of nutritional interventions on biomarkers of cellular senescence in humans: A systematic review.
04-jul-2026 novelty 3 per-area 2 strengthens
rss expert media
Metformin and cancer: active surveillance needed
04-jul-2026 novelty 2 per-area 2 weakens
pubmed review
From lifespan extension to hallmark-informed gerotherapeutic prioritization: A bibliometric-guided, strategy-oriented review of anti-aging drug research.
28-jun-2026 novelty 3 per-area 2 mentions
pubmed observational
Deep learning-based CT-derived vertebral bone mineral density and metformin therapy: a longitudinal study in the Multi-Ethnic Study of Atherosclerosis.
31-may-2026 novelty 2 per-area 2 strengthens

build build 880 · 2bcef25 · 2026-11-18